[Comparison of therapeutic agents for angina pectoris from the standpoint of experimental cardiodynamics--method of evaluation of chronotropism and inotropism].
作者信息
Ishiyama T, Morita Y, Tsukamoto N
出版信息
Nihon Rinsho. 1971 Sep;29(9):2159-66.
PMID:4399196
Abstract
摘要
相似文献
1
2
Ranolazine, a novel anti-anginal agent, does not alter isosorbide dinitrate- or sildenafil-induced changes in blood pressure in conscious dogs.雷诺嗪是一种新型抗心绞痛药物，不会改变硝酸异山梨酯或西地那非引起的清醒犬血压变化。
Eur J Pharmacol. 2006 Jul 17;541(3):171-6. doi: 10.1016/j.ejphar.2006.05.016. Epub 2006 May 17.
3
[Load insufficiency of the heart due to beta receptor blocking agents].β受体阻滞剂所致的心脏负荷不足
Med Klin. 1969 Sep 12;64(37):1663-8.
4
Organic nitrates in angina pectoris.
Arch Int Pharmacodyn Ther. 1972 Apr;196:Suppl 196: 25-.
5
[Metabolic effects of various palliative drugs for coronary insufficiency].[各种用于冠状动脉供血不足的姑息性药物的代谢效应]
Therapie. 1970 Mar-Apr;25(2):293-322.
6
7
The possible role of an adrenergic mechanism in the antianginal action of papaverine and prenylamine.肾上腺素能机制在罂粟碱和普尼拉明抗心绞痛作用中的可能作用。
Eur J Pharmacol. 1967 Oct;2(1):1-8. doi: 10.1016/0014-2999(67)90015-5.
8
9
Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.强效β-肾上腺素能受体拮抗剂心得多（LB-46）的心血管效应
J Clin Pharmacol New Drugs. 1971 Jul-Aug;11(4):249-60.
10
[The effect of amyl nitrite and beta-receptor-blocking substances on various blood circulation parameters administered singly as well as simultaneously].
Z Kreislaufforsch. 1968 Sep;57(9):876-83.
Zotero 插件